P450 oxidoreductase regulates barrier maturation by mediating retinoic acid metabolism in a model of the human BBB
DOI: 10.1016/j.stemcr.2022.07.010
Authors: Dor Zlotnik; Tatiana Rabinski; Aviv Halfon; Shira Anzi; Inbar Plaschkes; Hadar Benyamini; Yuval Nevo; Orly Yahalom Gershoni; Benyamin Rosental; Eli Hershkovitz; Ayal Ben-Zvi; Gad D. Vatine
Step 1: iPSC/ESC maintainance
day 0 ~ 3
culture “unspecified method” human PSC in “NutriStem” for “3” days. Medium should be changed once in “3” days.
Step 2: Primitive streak 1
day 3 ~ 4 (duration missing in database; assumed 1 day)
culture “unspecified method” human PSC in “DMEM/F12”. Medium should contain factors shown in the following table.
| concentration | unit | |
|---|---|---|
| KSR | 20 | % |
| NEAA | 1 | % |
| GlutaMAX | 0.5 | % |
| 2-mercaptoethanol | 2.2e-7 | mol/l |
| PSA | 1 | % |
Step 3: endothelial 1
day 4 ~ 6
culture “adherent” human PSC in “Endothelial SFM” for “2” days. Medium should contain factors shown in the following table, and should be changed once in “2” days.
| concentration | unit | |
|---|---|---|
| retinoic acid | 2.5e-7 | mol/l |
| FGF | 2.0e-5 | g/l |
Ideally, “EC” should express “ZO-1”, “GLUT-1”, “CLDN-5”, “OCLN” at the end of culture.
Step 4: endothelial 2
day 6 ~ 7 (duration missing in database; assumed 1 day)
culture “adherent” unknown species cell in “Endothelial SFM”. For ECM, use “fibronectin + collagen IV” at “N/A” “N/A”.